Riskpilot← Back to searchSign inGet full accessARCEDI BIOTECH ApS
APSActiveCVR 25577922Tabletvej 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 201322 employees
Revenue 2025
DKK -11,6M
-8% vs 2024
EBITDA margin
249.6%
-1% vs 2024
Equity ratio
-132.3%
Financial strength
Net profit 2025
DKK -45,9M
-9% vs 2024
| Revenue | DKK -11,6M | -8% |
| EBITDA | DKK -29M | -1% |
| Net profit | DKK -45,9M | -9% |
| Total assets | DKK 131,2M | -3% |
| Equity | DKK -173,6M | -36% |
| Employees | 22 | — |
Legal name
ARCEDI BIOTECH ApS
CVR number
25577922
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16. december 2013
Share capital
DKK 80.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af formanden i forening med
næstformanden eller af en direktør i forening med næstformanden eller af den
samlede bestyrelse i forening.
Company purpose
Selskabets formål er at drive virksomhed med forskning og udviklingsaktiviteter med henblik på kommercialisering samt anden virksomhed, der efter direktionens skøn er forbundet dermed
Address
Tabletvej 1
Phone
+4549288888
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -781 | -2.343 | 2.197 | 595 | 1.914 | 5.230 | 4.903 | 3.864 | -8.906 | -7.228 | -12.655 | -11.636 |
| Staff expenses | -665 | -660 | -4.099 | -5.887 | -7.633 | -8.683 | -9.357 | -10.403 | -13.873 | -16.436 | -16.012 | -17.409 |
| EBITDA | -1.446 | -3.003 | -1.902 | -5.292 | -5.719 | -3.453 | -4.454 | -6.539 | -22.779 | -23.664 | -28.667 | -29.045 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -47 | -95 | -95 | -95 | -6.789 | -8.228 | -8.792 | -9.191 |
| EBIT | -1.446 | -3.003 | -1.902 | -5.292 | -5.766 | -3.548 | -4.549 | -6.634 | -29.568 | -31.892 | -37.459 | -38.236 |
| Net financials | -69 | -230 | -505 | -695 | -1.046 | -1.343 | -1.767 | -2.246 | -3.668 | -10.324 | -13.255 | -12.009 |
| Profit before tax | -851 | -3.233 | -2.407 | -5.987 | -6.812 | -4.891 | -6.316 | -8.880 | -33.236 | -42.216 | -50.714 | -50.245 |
| Tax | 332 | -964 | -512 | -1.310 | -1.025 | -1.129 | -2.463 | -3.101 | -9.035 | -9.745 | -8.753 | -4.363 |
| Net profit | -1.183 | -2.269 | -1.895 | -4.677 | -5.787 | -3.762 | -3.853 | -5.779 | -24.201 | -32.471 | -41.961 | -45.882 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7.862 | 16.553 | 30.119 | 38.824 | 58.266 | 78.706 | 94.583 | 114.921 | 126.419 | 137.153 | 135.920 | 131.210 |
| Equity | -1.103 | -3.372 | -5.266 | -9.943 | -15.729 | -19.493 | -23.346 | -29.125 | -53.326 | -85.797 | -127.758 | -173.640 |
| Long-term debt | 0 | 0 | 30.097 | 0 | 0 | 306 | 0 | 0 | 164.864 | 211.217 | 259.008 | 303.518 |
| Short-term debt | 8.965 | 17.920 | 1.856 | 43.912 | 66.593 | 87.296 | 106.214 | 131.606 | 6.322 | 7.185 | 4.670 | 1.332 |
| Total debt | 8.965 | 17.920 | 31.953 | 43.912 | 66.593 | 87.602 | 106.214 | 131.606 | 171.186 | 218.402 | 263.678 | 304.850 |
EBITDA margin
-2904500000.0%
This company
15.8%
Market median
-18382911492% vs market
20142025
Equity ratio
-132.3%
This company
38.2%
Market median
-446% vs market
20142025
Return on equity
-4588200000.0%
This company
18.4%
Market median
-24935869665% vs market
20142025
Net profit margin
-4588200000.0%
This company
8.1%
Market median
-56644444544% vs market
20142025
Asset turnover
-0.09×
This company
1.12×
Market median
-108% vs market
20142025
Debt / equity
1.76×
This company
0.62×
Market median
-184% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2013-12-16 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MT Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
PS Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
JR Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2024 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BAKODO ApS | Company | 15.0% | 15.0% | 2023 |
EBS Zimba ApS | Company | 10.0% | 10.0% | 2023 |
BBS Zimba ApS | Company | 10.0% | 10.0% | 2023 |
LHBS Zimba ApS | Company | 10.0% | 10.0% | 2023 |
S.H.A.C. ApS | Company | 10.0% | 10.0% | 2024 |
SoLoCa ApS | Company | 10.0% | 10.0% | 2015 |
BAGGER-SØRENSEN & CO. A/S | Company | 10.0% | 10.0% | 2022 |
Zimba Invest ApS | Company | 5.0% | 5.0% | 2022 |
VECATA INVEST ApS | Company | 10.0% | 10.0% | 2015 |
S.H.A.C.ApS | Company | 10.0% | 15.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BAKODO ApS
ARCEDI BIOTECH ApS Board members of ARCEDI BIOTECH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mads Tang Dalsgaard | Chief Executive Officer | 0 companies |
| Palle Schelde Jensen | Chief Executive Officer | 0 companies |
| John Riis Mortensen | Management | 0 companies |
| Claus Bagger-Sørensen | Deputy Chairman | 0 companies |
| Tonni Bülow-Nielsen | Chairman | 0 companies |
| Steen Bagger-Sørensen | Board of Directors | 0 companies |
| Hans-Henrik Horsted Eriksen | Board of Directors | 0 companies |
| Søren Birn | Board of Directors | 0 companies |